Brief: Dexcom Announces Governance Enhancements Ahead Of 2026 Investor Day
14/05/2026 21:20
May 14 (Reuters) - Dexcom Inc DXCM.O: DEXCOM ANNOUNCES GOVERNANCE ENHANCEMENTS AHEAD OF 2026 INVESTOR DAY DEXCOM INC - TO ADD TWO INDEPENDENT DIRECTORS WITH MEDTECH AND OPERATIONS EXPERIENCE DEXCOM INC - CO AND ELLIOTT INVESTMENT MANAGEMENT TO COLLABORATE ON IDENTIFYING TWO NEW INDEPENDENT BOARD MEMBERS DEXCOM INC - EXPANDS OPERATIONS AND INNOVATION COMMITTEE MANDATE TO OVERSEE OPERATIONS, QUALITY, TECHNICAL ROADMAP Source text: ID:nBw5cpRsHa Further company coverage: DXCM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on DexCom
See all newsU.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
FDA clears first over-the-counter glucose monitor for children
Brief: FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers